Nabriva Therapeutics plc NBRV
1.42 +1.42
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 217.00K | 637.00K | 820.00K | 396.00K | 510.00K | |
| 1.85M | 66.37M | 26.92M | 56.08M | 92.92M | |
| -35.30M | 6.24M | -44.82M | -15.59M | 15.23M | |
| -211.00K | -25.00K | -113.00K | -61.00K | -229.00K | |
| 2.12M | 27.91M | 54.17M | 20.51M | 50.00M | |
| 539.00K | 42.28M | -22.48M | 37.92M | 47.76M | |
| -263.00K | -81.00K | -274.00K | 331.00K | -4.60M | |
| -36.71M | -59.56M | -71.33M | -71.89M | -72.72M | |
| -174.00K | -484.00K | -140.00K | -106.00K | -362.00K | |
| 1.97M | 3.29M | 5.22M | 9.75M | 5.15M |